Publication | Closed Access

Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II

Health PolicyCardiovascular DiseaseB Target LevelsHyperlipidemiaLdl CholesterolPharmacotherapyDyslipidemiaPublic HealthEpidemiologyNon-hdl Cholesterol